147 related articles for article (PubMed ID: 29665882)
1. Effects of antibiotic resistance (AR) and microbiota shifts on Campylobacter jejuni-mediated diseases.
Brooks PT; Mansfield LS
Anim Health Res Rev; 2017 Dec; 18(2):99-111. PubMed ID: 29665882
[TBL] [Abstract][Full Text] [Related]
2. Transplanted human fecal microbiota enhanced Guillain Barré syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice.
Brooks PT; Brakel KA; Bell JA; Bejcek CE; Gilpin T; Brudvig JM; Mansfield LS
Microbiome; 2017 Aug; 5(1):92. PubMed ID: 28789710
[TBL] [Abstract][Full Text] [Related]
3. An antibiotic depleted microbiome drives severe Campylobacter jejuni-mediated Type 1/17 colitis, Type 2 autoimmunity and neurologic sequelae in a mouse model.
Brooks PT; Bell JA; Bejcek CE; Malik A; Mansfield LS
J Neuroimmunol; 2019 Dec; 337():577048. PubMed ID: 31678855
[TBL] [Abstract][Full Text] [Related]
4. Guillain Barré Syndrome is induced in Non-Obese Diabetic (NOD) mice following Campylobacter jejuni infection and is exacerbated by antibiotics.
St Charles JL; Bell JA; Gadsden BJ; Malik A; Cooke H; Van de Grift LK; Kim HY; Smith EJ; Mansfield LS
J Autoimmun; 2017 Feb; 77():11-38. PubMed ID: 27939129
[TBL] [Abstract][Full Text] [Related]
5. Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice.
Haag LM; Fischer A; Otto B; Plickert R; Kühl AA; Göbel UB; Bereswill S; Heimesaat MM
PLoS One; 2012; 7(5):e35988. PubMed ID: 22563475
[TBL] [Abstract][Full Text] [Related]
6.
Malik A; Brudvig JM; Gadsden BJ; Ethridge AD; Mansfield LS
Gut Microbes; 2022; 14(1):2064706. PubMed ID: 35442154
[No Abstract] [Full Text] [Related]
7. Autoimmunity and cytokines in Guillain-Barré syndrome revisited: review of pathomechanisms with an eye on therapeutic options.
Ebrahim Soltani Z; Rahmani F; Rezaei N
Eur Cytokine Netw; 2019 Mar; 30(1):1-14. PubMed ID: 31074417
[TBL] [Abstract][Full Text] [Related]
8. Influence of the Gut Microbiota Composition on Campylobacter jejuni Colonization in Chickens.
Han Z; Willer T; Li L; Pielsticker C; Rychlik I; Velge P; Kaspers B; Rautenschlein S
Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28808158
[TBL] [Abstract][Full Text] [Related]
9. Campylobacter jejuni capsular genotypes are related to Guillain-Barré syndrome.
Heikema AP; Islam Z; Horst-Kreft D; Huizinga R; Jacobs BC; Wagenaar JA; Poly F; Guerry P; van Belkum A; Parker CT; Endtz HP
Clin Microbiol Infect; 2015 Sep; 21(9):852.e1-9. PubMed ID: 26070960
[TBL] [Abstract][Full Text] [Related]
10. Murine infection models for the investigation of Campylobacter jejuni--host interactions and pathogenicity.
Heimesaat MM; Bereswill S
Berl Munch Tierarztl Wochenschr; 2015; 128(3-4):98-103. PubMed ID: 25876268
[TBL] [Abstract][Full Text] [Related]
11. Microbiota-Derived Short-Chain Fatty Acids Modulate Expression of
Luethy PM; Huynh S; Ribardo DA; Winter SE; Parker CT; Hendrixson DR
mBio; 2017 May; 8(3):. PubMed ID: 28487428
[No Abstract] [Full Text] [Related]
12. Resistance mechanisms in Campylobacter jejuni.
Iovine NM
Virulence; 2013 Apr; 4(3):230-40. PubMed ID: 23406779
[TBL] [Abstract][Full Text] [Related]
13. Glycoconjugates play a key role in Campylobacter jejuni Infection: interactions between host and pathogen.
Day CJ; Semchenko EA; Korolik V
Front Cell Infect Microbiol; 2012; 2():9. PubMed ID: 22919601
[TBL] [Abstract][Full Text] [Related]
14. Co-infection with two different Campylobacter jejuni strains in a patient with the Guillain-Barré syndrome.
Godschalk PC; Gilbert M; Jacobs BC; Kramers T; Tio-Gillen AP; Ang CW; Van den Braak N; Li J; Verbrugh HA; Van Belkum A; Endtz HP
Microbes Infect; 2006 Jan; 8(1):248-53. PubMed ID: 16213180
[TBL] [Abstract][Full Text] [Related]
15. The immunobiology of Campylobacter jejuni: Innate immunity and autoimmune diseases.
Phongsisay V
Immunobiology; 2016 Apr; 221(4):535-43. PubMed ID: 26709064
[TBL] [Abstract][Full Text] [Related]
16. Guillain-Barré syndrome associated with Campylobacter jejuni infection in England, 2000-2001.
Tam CC; Rodrigues LC; O'Brien SJ
Clin Infect Dis; 2003 Jul; 37(2):307-10. PubMed ID: 12856224
[TBL] [Abstract][Full Text] [Related]
17. Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome.
Schmidt-Ott R; Schmidt H; Feldmann S; Brass F; Krone B; Gross U
Clin Vaccine Immunol; 2006 Jul; 13(7):779-83. PubMed ID: 16829615
[TBL] [Abstract][Full Text] [Related]
18.
Stein RA
ACS Infect Dis; 2022 Oct; 8(10):1981-1991. PubMed ID: 36137262
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.
Koga M; Gilbert M; Takahashi M; Li J; Koike S; Hirata K; Yuki N
J Infect Dis; 2006 Feb; 193(4):547-55. PubMed ID: 16425134
[TBL] [Abstract][Full Text] [Related]
20. Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms.
Dasti JI; Tareen AM; Lugert R; Zautner AE; Gross U
Int J Med Microbiol; 2010 Apr; 300(4):205-11. PubMed ID: 19665925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
